You Can See: Holmes Doc Expands to 2,600 Theaters
Photos Courtesy of A24/CNM247 Photo Designers

You Can See: Holmes Doc Expands to 2,600 Theaters

A three-hour Elizabeth Holmes documentary just did what no documentary in fewer than 1,000 theaters had ever done — and A24 is rewarding it with a nationwide expansion. Here’s why You Can See is breaking records.

By The Cinephile — CelebnMusic247

The strangest box-office story of the fall is no longer a sleeper — it is a stampede. You Can See Everything, A24’s nearly three-hour documentary about disgraced Theranos founder Elizabeth Holmes, will expand into more than 2,600 theaters this week after a debut nobody in the industry forecast, per Collider.

You Can See: Holmes Doc Expands to 2,600 Theaters
Photos Courtesy of A24/CNM247 Photo Designers

Start with the number that broke the model. The film opened to $15 million in just 855 theaters, with a reported 2,000 sold-out shows, per Collider — the second-biggest opening ever for a documentary, behind only Michael Moore’s Fahrenheit 9/11. Then the week delivered a first: per Collider, no documentary playing in fewer than 1,000 theaters had ever topped the domestic box-office chart until this one overtook the video game adaptation Street Fighter to do exactly that.

You Can See: A platform release that became an event

A24 played this like a heist in reverse — building scarcity first, then opening the doors. The film’s existence was revealed at this year’s Telluride Film Festival, per Collider, and the studio spent the following weeks cementing its event status with an air of exclusivity before the platform launch. Co-directed by Nathan Fielder and Lance Oppenheim, it follows Holmes in the weeks leading up to her incarceration for fraud, and critics have met it as something stranger and richer than a true-crime recap. It sits at a Certified Fresh 97% on Rotten Tomatoes, per Collider, whose reviewer Samuel R. Murrian called it “a true original that will absolutely continue to surge in the awards season conversation.”

Now comes the real test. Per Collider, the expansion eyes roughly $25 million to $30 million this weekend — large enough to challenge DC Studios’ Clayface, which is expecting a domestic debut around $30 million on divisive early reviews. A three-hour documentary about a convicted fraudster, made in secret and sold on word of mouth, is in a genuine fight for the No. 1 spot against a comic-book horror movie opening in Halloween season. Nobody’s tracking model had that square on the board.

The deeper story is who is buying the tickets. Reporting around the opening has stressed how young the audience skews and how completely the film has behaved like a fandom event rather than a documentary release — sold-out shows, repeat chatter, a filmmaker with a devoted following treating nonfiction like a midnight movie. The expansion will tell us whether that heat was a one-weekend phenomenon or the start of a long, profitable run.

The 247 Take — Documentaries are not supposed to do this, which is exactly why this one is. Fielder and Oppenheim made the film nobody could categorize, A24 sold it like contraband, and audiences responded like it was a blockbuster. If it takes the weekend from a DC movie, the lesson lands hard: in 2026, the scarcest blockbuster fuel is genuine surprise.

More movie news at CelebnMusic247.com.

Sources: Collider